Results 11 to 20 of about 24 (24)

MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma

Biomarkers, 2009
Nobuyoshi Kosaka, Fumiaki Koizumi, Takayuki Mizutani   +2 more
exaly  

Forecasting S&P 500 index using artificial neural networks and design of experiments

Journal of Industrial Engineering International, 2013
Seyed Taghi Akhavan Niaki, Niaki Seyed Taghi Akhavan   +1 more
exaly  

Transparency among S&P 500 companies: an analysis of ESG disclosure scores

Management Decision, 2017
Nabil Tamimi, Rose Sebastianelli
exaly  

Inhibition of microRNA‐500 has anti‐cancer effect through its conditional downstream target of TFPI in human prostate cancer

Prostate, 2017
Yue Pan, Yeping Li
exaly  

How Sustainability Is Reflected in the S&P 500 Companies’ Strategic Documents

Organization and Environment, 2017
NABIN Baral
exaly  

Extreme Insulin Resistance: Indications and Approaches to the Use of U-500 Insulin in Type 2 Diabetes Mellitus

Current Diabetes Reports, 2010
Lisa R Tannock, Tannock Lisa R
exaly  

Clinical Use of U-500 Regular Insulin: Review and Meta-Analysis

Journal of Diabetes Science and Technology, 2012
Kristen Wroblewski
exaly  

The analysis of the influence of globe SST anomalies on 500 hPa temperature field based on Bayesian

Wuli Xuebao/Acta Physica Sinica, 2012
Qian Zhong-Hua, He Wen-Ping
exaly  

Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized ‘FIRST’ study

Breast Cancer Research and Treatment, 2012
John F R Robertson, Justin P O Lindemann, Antonio Llombart-Cussac   +2 more
exaly  

Sustainable business model adoption among S&P 500 firms: A longitudinal content analysis study

Journal of Cleaner Production, 2018
Paavo Ritala, Pontus Huotari, Nancy Bocken   +2 more
exaly